Lan Zhu is a Director at Shanghai Chempartner, where they have led metabolic and cardiovascular disease services since 2014. With over 20 years of pharmaceutical R&D experience, they possess extensive expertise in biomarker assay development and validation for drug candidates, particularly in the area of Type II Diabetes. Prior to this role, Lan served in various senior positions at Merck, contributing to multiple diabetes drug discovery programs. They hold a Master’s degree in Immunology & Microbiology from Chinese CDC and a Master’s in Microbiology & Molecular Biology from UMDNJ, and are currently pursuing an M.D. in Public Health at Sichuan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices